Tag Archives: patents

Federal Circuit Denies En Banc Review of Athena v. Mayo

Posted on July 7, 2019 by Warren Woessner

On July 3rd, the Fed. Cir. denied Athena’s petition for rehearing en banc. The three-page order is a 7/5 denial accompanied by more than 80 pages of concurrences and dissents. Concurring in various combinations are Judges Lourie, Hughes, Dyk, Reyna, … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

USPTO Post-Prosecution Pilot Program Launches

Posted on July 12, 2016 by Warren Woessner

A guest post from Edward Sandor, attorney at Schwegman. The Post-Prosecution Pilot Program (P3) launched at the USPTO Monday, combining features of the AFCP 2.0 and Pre-Appeal Brief Conference Pilot programs, with the notable addition of Applicant participation in the process. … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment

FDA Releases Outline of Guidance for Developing Tests Based on Human Genetic Variants

Posted on July 8, 2016 by Warren Woessner

The FDA is charged with regulating “Next Generation Sequencing (NGS) Tests,” and has just released draft guidance on what needs to be regulated. (A copy of the first draft and second draft can be found at the end of this … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

Rapid Litigation v. CellzDirect – A Break in the 101 Wall

Posted on July 5, 2016 by Warren Woessner

On July 5, 2016, a three – judge Fed. Circuit panel of Moore, Prost and Stoll (Appeal no. 2015-1570) reversed the district court’s holding that claims to a method of isolating “hardy” twice -frozen hepatocytes (as I called them in my … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | 1 Comment